September 28, 2016
2 min read
Save

Standard structural measures can identify progression in advanced glaucoma

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Structural changes within advanced glaucoma can be identified by monitoring macular retinal ganglion cell-inner plexiform layer, and 3D whole-volume Bayesian-kernel detection scheme change shows promise in detecting progression in advanced disease, according to researchers in Investigative Ophthalmology & Visual Science.

Researchers included 35 eyes of 35 patients with advanced glaucoma and 46 eyes of 30 healthy subjects.

Circumpapillary retinal fiber layer thickness (cpRNFL), minimum rim width (MRW) and macular retinal ganglion cell-inner plexiform layer (GCIPL) thicknesses were measured using the San Diego Automated Layer Segmentation Algorithm (SALSA).

In advanced-glaucoma eyes, the mean rates of cpRNFL, MRW and macular GCIPL change were -0.08 µm/y, -0.29 µm/y and -0.18 µm/y, respectively, according to researchers.

No significant difference was found between the mean rate of loss of cpRNFL and MRW in advanced-glaucoma eyes and healthy eyes. The mean rate of macular GCIPL loss was typically larger in advanced-glaucoma eyes than in healthy eyes, but the difference in mean rates between groups was not significant.

“Our results suggest than even in very advanced glaucoma, structural loss can be detected in some eyes using standard global structural measures,” the researchers wrote.

Macular GCIPL had the highest proportion of eyes with detectable change followed by MRW and cpRNFL.

The researchers concluded that monitoring macular GCIPL and 3D whole-volume BKDS change shows promise for identifying progression in advanced glaucoma. – by Abigail Sutton

Disclosure: Belghith reported no financial disclosures. Please see the full study for all remaining authors’ relevant financial disclosures.